Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis
Combining both with GLP-1 treatment produces significantly better lean mass preservation outcomes than either intervention alone, and far better than the drug alone
Results showed meaningful weight reduction, but the study also documented side effects including nausea, vomiting, and gastrointestinal complaints that were more frequent than placebo
Moreover, age-related insulin resistance, regardless of weight or diagnosis, improves with GLP-1 treatment
Our SlimShot Essential is a GLP-1 receptor agonist that aids in insulin production, signaling fullness to the brain and impacting gastric emptying
Mini-mental state: a practical method for grading the cognitive state of patients for the clinician